#join
BioMarin, Jazz Pharmaceuticals, and Otsuka CEOs to Join NORD CEO for High-Level Dialogue on Transforming Scientific Innovation Into Patient Progress
WASHINGTON, D.C. and NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has announced that CNBC “Squawk...
BioMarin, Jazz Pharmaceuticals, and Otsuka CEOs to Join NORD CEO for High-Level Dialogue on Rare Disease Innovation
WASHINGTON, D.C. and NORWELL, Mass. — In an era defined by unprecedented scientific breakthroughs, the ultimate measure of...
Spear and NewYork-Presbyterian Join Forces to Expand Outpatient Rehabilitation Across New York Metropolitan Area
The landscape of outpatient rehabilitation and musculoskeletal care in the greater New York metropolitan area is set for...